Exploration of the chondrosarcoma metabolome; the mTOR pathway as an important pro-survival pathway

Addie, R.D.; Yvonne, D.; Alberti, G.; Kruisselbrink, A.B.; Que, I.; Baelde, H.; Bovee, J.V.M.G. (2019)

Article / Letter to editor

• Chondrosarcoma
• Metabolism
• mTOR, Sapanisertib
• Rapamycin

• All authors: Addie, R.D.; Yvonne, D.; Alberti, G.; Kruisselbrink, A.B.; Que, I.; Baelde, H.; Bovee, J.V.M.G.
• Date: 2019-04-30
• Journal: Journal of Bone Oncology
• Volume: 15
• DOI: doi:10.1016/j.jbo.2019.100222